keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
MAIN CONFERENCE DEC. 15 - PST/PDT (Pacific Daylight, GMT-7)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
MAIN CONFERENCE DEC. 15 - PST/PDT (Pacific Daylight, GMT-7)
search
Streams
Formats
6:30am - 7:15am
Sunrise Yoga: Wellness Event
Showing 2 of 2 Streams
Scientific Breakfast Briefing #1
Scientific Breakfast Briefing #2
7:30am - 8:00am
AI + Site-Specific Integration Technology Predictable Cell Pool for Drug Development
- Michael Chen, PhD - CEO & Co-founder, Great Bay Bio
7:30am - 8:00am
Integrated Discovery and Functional Testing of Novel CAR-T Constructs Targeting Peptide/MHC Complexes
- William Carson IV, PhD - Head of Translational Medicine, Alloy Therapeutics
Showing 2 of 2 Streams
Track 1: Antibody Therapies in Tumor Microenvironment
Track 2: Antibody-Based Degraders for Therapeutic Development
8:10am - 8:15am
Co-Chairs’ Remarks
- Jennifer Cochran, Ph.D. - Professor and Department Chair of Bioengineering, Stanford University
- Jun Wang, Ph.D. - Assistant Professor, Department of Pathology, NYU Grossman School of Medicine
8:15am - 8:45am
LILRBs - Myeloid Checkpoint Targets for Cancer Treatment
- Chengcheng (Alec) Zhang, Ph.D. - Professor, Department of Physiology, UT Southwestern Medical Center
8:45am - 9:15am
Activating Clustering-dependent Receptors through IgG Hexamers – HexaBody-CD27
- Esther Breij, PhD - Vice President, Head of Translational Research, Genmab BV
9:15am - 9:45am
Therapeutic Targeting of Regulatory B-cells in Solid Tumors
- Paul Tumeh - Co-Founder and CEO, Biograph55
8:10am - 8:15am
Chairwoman’s Remarks
- Katherine Harris, PhD - Chief Development Officer, Rondo Therapeutics
8:15am - 8:45am
Turning Intracellular Antibodies into Biodegraders and Using Antibody Paratopes for Chemical Surrogates
- Terry Rabbitts - Professor of Molecular Immunology, Institute of Cancer Research
8:45am - 9:15am
Engineering Proteolysis-targeting Antibodies (PROTABs) to Degrade Cell-surface Proteins
- Wenting Tsai - Scientist 3, Genentech
9:15am - 9:45am
Development of TPD2, A Dual-precision Approach for Targeted Delivery of Targeted Protein Degraders
- James Palacino - Vice President and Head of Biology, Orum Therapeutics
9:45am - 10:30am
Networking Refreshment Break, Exhibit and Poster Viewing
Showing 2 of 2 Streams
Track 1: Antibody Therapies in Tumor Microenvironment
Track 2: Antibody-Based Degraders for Therapeutic Development
10:30am - 11:00am
Targeting the Novel Immune Checkpoint VISTA Using a Rational Antibody Development Strategy
- Jerome Boyd-Kirkup, Ph.D. - Chief Scientific Officer and Co-Founder, Hummingbird Bioscience
11:00am - 11:30am
CD93 Blockade for Tumor Vascular Normalization
- Yuwen Zhu, Ph.D. - Associate Professor, Surgical Oncology Division, University of Colorado Denver
11:30am - 12:00pm
The Perspective of STING Agonists and IL-35 Blockade in Solid Tumor Therapy
- Sirui Li, PhD - Research Associate, Laboratory of Dr. Jenny Ting, University of North Carolina at Chapel Hill
10:30am - 11:00am
Strategies for the Treatment of Antibody-mediated Autoimmunity
- Sally Ward, PhD - Professor and Director, University of Southampton
11:00am - 11:30am
Harnessing Modular E3 Ligase and Cytokine Receptor Targeting Chimeras to Degrade Cell-surface and Extracellular Proteins
- Josef Gramespacher, PhD - Co-founder and Senior Scientist, EpiBiologics
11:30am - 12:00pm
Sweeping Antibodies
- Taichi Kuramochi - Head of Biologics Discovery Department, Chugai Pharmaceutical Co., Ltd.
Showing 5 of 5 Streams
Scientific Briefing 1
Scientific Briefing 2
Scientific Briefing 3
Scientific Briefing 4
Scientific Briefing 5
12:05pm - 12:35pm
Wrangling Diverse OmniAb Antibody Repertoires with OmniDeep
- Bob Chen, PhD - Senior Director, Systems Engineering, OmniAb
12:05pm - 12:35pm
Briefing by GenScript
12:05pm - 12:35pm
Briefing by Genovac
12:05pm - 12:35pm
Briefing by Berkeley Lights
12:05pm - 12:35pm
Briefing by Abcellera
12:35pm - 1:45pm
Networking Luncheon, Exhibit and Poster Viewing
Showing 5 of 5 Streams
Scientific Briefing 1
Scientific Briefing 2
Scientific Briefing 3
Scientific Briefing 4
Scientific Briefing 5
1:45pm - 2:15pm
The BioXp® System: Accelerating Hit-to-Lead Discovery by Breaking through Critical Synthesis Bottlenecks
- Jason Lehmann, PhD - Senior Product Marketing Manager, Telesis Bio
1:45pm - 2:15pm
Briefing by Chemical Computing
1:45pm - 2:15pm
Antibody Sequence and Structure-based Workflows for Diversity and Developability Assessments
- Vinodh Kurella, PhD - Senior Scientist, Takeda
- Monica Watson, PhD - Field Application Scientist, Geneious Biologics
1:45pm - 2:15pm
Briefing by Pall
1:45pm - 2:15pm
Briefing by Pelican
Showing 2 of 2 Streams
Track 1: Harnessing Antibodies for Autoimmunity and Inflammation
Track 2: Immune Cell Engager Antibody Technologies
2:25pm - 2:30pm
Co-Chairs’ Remarks
- Shannon Turley, PhD - Vice President and Therapeutic Area Head, Immunology and Regenerative Medicine, Genentech
- Jo Viney, Ph.D. - Founder, President and CEO, Seismic Therapeutic
2:30pm - 3:00pm
The Application of Generative Biology to Accelerate Therapeutics for Treating Immune Mediated Diseases
- Kristen Hopson, Ph.D. - Vice President of Preclinical Discovery and Develo, Generate Biomedicines
3:00pm - 3:30pm
A Deep Learning Pipeline for Protein Binder Design
- Nate Bennett, Ph.D. - Postdoctoral Fellow, University of Washington
3:30pm - 4:00pm
From the Laboratory to the Clinic: Anti-TNF and Anti-IL-23 Combination Therapy in Inflammatory Bowel Disease
- Jennifer Towne, PhD - Vice President Immunology Discovery and External Innovation, Johnson & Johnson
2:25pm - 2:30pm
Chairman’s Remarks
- Jamie Spangler, Ph.D. - Assistant Professor, Johns Hopkins University
- Shelley Force Aldred, Ph.D. - Co-Founder & CEO, Rondo Therapeutics
2:30pm - 3:00pm
Engaging Adaptive and Innate Immune Systems with Bispecific Antibodies Targeting CD28 or CD47
- Nicolas Fischer, Ph.D. - CEO, Light Chain Bioscience
3:00pm - 3:30pm
XTEN® Polypeptide-masked Protease Activated T Cell Engager (XPAT®): A Novel Format to Mitigate the On-Target, Off-Tumor Problem
- Tracy Young, PhD - Director, Protein Engineering, Amunix Pharmaceuticals, Inc, a Sanofi Co
3:30pm - 4:00pm
Bispecific Immune Engagers Targeting Cancer-specific Neoantigens Created by Design
- Shohei Koide, PhD - Professor of Biologics Design, Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine
4:00pm - 4:45pm
Networking Refreshment Break, Exhibit and Poster Viewing
Showing 2 of 2 Streams
Track 1: Harnessing Antibodies for Autoimmunity and Inflammation
Track 2: Immune Cell Engager Antibody Technologies
4:45pm - 5:15pm
Next Generation Therapies for Treating Autoimmunity and Inflammation
- Alison Budelsky, Ph.D. - Vice President Immunology Research, Eli Lilly & Company
5:15pm - 5:45pm
Targeting Inhibitory Receptors for Controlling Inflammation
- Steven Rust - Senior Director Protein Engineering, Gilead Sciences
5:45pm - 6:15pm
Engineering of Antibodies for Optimal FcRn Engagement
- Maximilian Brinkhaus, PhD - Scientist, Argenx
4:45pm - 5:15pm
Targeting Multiple Activating Pathways with Natural Killer Cell Engagers
- Katrina Bykova, PhD - Group Leader, Discovery Biology & Pharmacology, Xencor
5:15pm - 5:45pm
Improved Tolerability and Tumor Specific Delivery of a Therapeutic Bispecific T Cell Engager Using a pH-Sensitive Nanoparticle Platform
- Tian Zhao, PhD - Vice President of R&D, OncoNano Medicine Inc.
5:45pm - 6:15pm
Immune Cell Engager Antibdies
- Werner Meier - Chief Scientific Officer, Revitope Oncology
6:15pm - 7:15pm
Networking Reception, Exhibit and Poster Viewing
7:00pm-10:00pm - OmnidAb™ “Heavy Chain” Party Exclusive Event– 90’s Themed Reception ** INVITATION ONLY **
Showing 1 of 1 Streams
Join OmniAb for an exclusive event to celebrate the launch of OmnidAb, the world's first and only transgenic chicken producing human heavy chain only antibodies Event taking place at the Marriott Marquis Rancho Santa Fe Rooms at 7:00 pm. PLEASE CONTACT: RSVP@OMNIAB.COM for invitation details.
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Formats